Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Science

• Publication date

  1998-11-27

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1126/SCIENCE.282.5394.1669PMID 9831551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural and functional insights provided by crystal structures of DNA polymerases and their substrate complexes.

  1998cited by this paper
• Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 Å resolution

  1998cited by this paper
• Visualizing DNA replication in a catalytically active Bacillus DNA polymerase crystal

  1998cited by this paper
• Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89

  1997cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Current knowledge of HIV-1 reverse transcriptase mutations selected during nucleoside analogue therapy: the potential to use resistance data to guide clinical decisions.

  1997cited by this paper
• Conferring RNA polymerase activity to a DNA polymerase: a single residue in reverse transcriptase controls substrate selection.

  1997cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• A minor groove binding track in reverse transcriptase

  1997cited by this paper
• DISULFIDE CROSS-LINKING AS A MECHANISTIC PROBE FOR THE B Z TRANSITION IN DNA

  1997cited by this paper
• Selective base-pair destabilization enhances binding of a DNA methyltransferase

  1997cited by this paper
• Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC.

  1997cited by this paper
• Crystal structures of human DNA polymerase beta complexed with gapped and nicked DNA: evidence for an induced fit mechanism.

  1997cited by this paper
• Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant.

  1996cited by this paper
• Antiretroviral drug resistance: mechanisms, pathogenesis, clinical significance.

  1996cited by this paper
• Structural mechanisms of HIV drug resistance.

  1996cited by this paper
• Viral Dynamics of HIV: Implications for Drug Development and Therapeutic Strategies

  1996cited by this paper
• Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase.

  1995cited by this paper
• Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution.

  1995cited by this paper
• The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.

  1995cited by this paper
• Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors.

  1995cited by this paper
• Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy.

  1995cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor α-APA R 95845 at 2.8 å resolution

  1995cited by this paper
• Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors

  1995cited by this paper
• High resolution structures of HIV-1 RT from four RT–inhibitor complexes

  1995cited by this paper
• Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

  1995cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.

  1994cited by this paper
• Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase

  1994cited by this paper
• Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine

  1994cited by this paper
• Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.

  1994cited by this paper
• Comparison of three different crystal forms shows HIV-1 reverse transcriptase displays an internal swivel motion.

  1994cited by this paper
• Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.

  1993cited by this paper
• Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.

  1993cited by this paper
• Co-crystal structure of TBP recognizing the minor groove of a TATA element

  1993cited by this paper
• Crystal structure of a yeast TBP/TATA-box complex

  1993cited by this paper
• Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.

  1993cited by this paper
• Biochemical studies on the reverse transcriptase and RNase H activities from human immunodeficiency virus strains resistant to 3'-azido-3'-deoxythymidine.

  1992cited by this paper
• Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.

  1992cited by this paper
• X-PLOR Version 3.1: A System for X-ray Crystallography and NMR

  1992cited by this paper
• Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.

  1992cited by this paper
• Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine

  1992cited by this paper
• Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine.

  1992cited by this paper
• Improved methods for building protein models in electron density maps and the location of errors in these models.

  1991cited by this paper
• Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons

  1991cited by this paper
• Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.

  1991cited by this paper
• Molecular targets for AIDS therapy.

  1990cited by this paper
• HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.

  1989cited by this paper
• Point mutations in conserved amino acid residues within the C‐terminal domain of HIV‐1 reverse transcriptase specifically repress RNase H function

  1989cited by this paper
• Ribbon models of macromolecules

  1987cited by this paper
• Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

  1986cited by this paper
• Antiviral chemotherapy.

  1966cited by this paper

• Kinetic Insights into the Enhanced Antiviral Activity of Islatravir against Doravirine Resistance-Associated Substitution Mutations in HIV-1 Reverse Transcriptase.

  2025cites this paper
• Mechanistic basis for a novel dual-function Gag-Pol dimerizer potentiating CARD8 inflammasome activation and clearance of HIV-infected cells

  2025cites this paper
• Mechanism for Nucleotidyl Transfer in LINE-1 ORF2p Revealed by QM/MM Simulations

  2025cites this paper
• A Model of Non-Homologous Recombination Mediated by HIV-1 Reverse Transcriptase Explaining Sequence Motif Duplications That Confer a Replication Fitness Advantage

  2025cites this paper
• Mechanism and spectrum of inhibition of viral polymerases by 2′-deoxy-2′-β-fluoro-4′-azidocytidine or azvudine

  2025cites this paper
• Deciphering the structural consequences of R83 and R152 methylation on DNA polymerase β using molecular modeling

  2025cites this paper
• Disassembly activates Retron-Septu for antiphage defense.

  2025cites this paper
• Structural basis of deoxynucleotide addition by HIV-1 RT during reverse transcription

  2024influential citation
• Nucleotide analogues and Mpox : Repurposing the repurposable.

  2024cites this paper
• Small Molecule Drugs Targeting Viral Polymerases

  2024cites this paper
• Potential novel HIV-1 reverse transcriptase inhibitors: a modeling and evaluation approach

  2024cites this paper
• Technologies for Targeted RNA Degradation and Induced RNA Decay

  2024cites this paper
• Structural basis for C2'-methoxy recognition by DNA polymerases and function improvement.

  2024cites this paper
• Inhibitors against DNA Polymerase I Family of Enzymes: Novel Targets and Opportunities

  2024cites this paper
• Human Immunodeficiency Viral Reverse Transcriptases: Analyses of the Active Sites of the Polymerase Domain and Drug-Resistant Mutants of the Reverse Transcriptases

  2024cites this paper
• Islatravir: evaluation of clinical development for HIV and HBV

  2024cites this paper
• Investigation of COVID-19 virus mutagenicity and the effect of the NSP13, NSP14, and NSP16 on the -1 ribosomal frameshifting

  2024cites this paper
• Machine intelligence-guided selection of optimized inhibitor for human immunodeficiency virus (HIV) from natural products

  2023cites this paper
• Structural insights into the assembly and mechanism of mpox virus DNA polymerase complex F8-A22-E4-H5.

  2023cites this paper
• History of advances in enzyme kinetic methods: From minutes to milliseconds.

  2023cites this paper
• Preparation of DNA and RNA Fragments Containing Guanine N2‐Thioalkyl Tethers

  2023cites this paper
• Comprehensive in vitro susceptibility analysis of simian retrovirus type 4 to antiretroviral agents( Dissertation_全文 )

  2023cites this paper
• Internal RNA 2′-O-methylation on the HIV-1 genome impairs reverse transcription

  2023cites this paper
• Structural and computational studies of HIV-1 RNA

  2023cites this paper
• Charge engineering of the nucleic acid binding cleft of a thermostable HIV-1 reverse transcriptase reveals key interactions and a novel mechanism of RNase H inactivation.

  2023cites this paper
• Reverse Transcriptases: From Discovery and Applications to Xenobiology

  2022cites this paper
• Novel RNase H inhibitors blocking RNA-directed strand displacement DNA synthesis by HIV-1 reverse transcriptase.

  2022cites this paper
• Mutations in the monkeypox virus replication complex: Potential contributing factors to the 2022 outbreak

  2022cites this paper
• Mechanistic Interplay between HIV-1 Reverse Transcriptase Enzyme Kinetics and Host SAMHD1 Protein: Viral Myeloid-Cell Tropism and Genomic Mutagenesis

  2022influential citation
• Crystal structure of a pre-chemistry viral RNA-dependent RNA polymerase suggests participation of two basic residues in catalysis

  2022influential citation
• Structural and Molecular Kinetic Features of Activities of DNA Polymerases

  2022cites this paper
• Structural Insights into Binding of Remdesivir Triphosphate within the Replication–Transcription Complex of SARS-CoV-2

  2022cites this paper
• New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?

  2022cites this paper
• Within and Beyond the Nucleotide Addition Cycle of Viral RNA-dependent RNA Polymerases

  2022cites this paper
• Predicted structure of the hepatitis B virus polymerase reveals an ancient conserved protein fold

  2022cites this paper
• Cryo-EM structures of Doravirine and Rilpivirine with HIV-1 Reverse Transcriptase/DNA Aptamer – Nonnucleoside Inhibitor Resistance by E138K and M184I Mutations

  2022cites this paper
• Insights into HIV-1 Reverse Transcriptase (RT) Inhibition and Drug Resistance from Thirty Years of Structural Studies

  2022influential citation
• Special Collection: A pioneer in antiviral drug discovery and development: Commemorating John Martin-Review

  2022cites this paper
• Cryo-EM structures of wild-type and E138K/M184I mutant HIV-1 RT/DNA complexed with inhibitors doravirine and rilpivirine

  2022cites this paper
• Structural basis of transition from initiation to elongation in de novo viral RNA-dependent RNA polymerases

  2022cites this paper
• Editorial: Nucleic Acid Polymerases: The Two-Metal-Ion Mechanism and Beyond

  2022cites this paper
• RNA binding proteins

  2022cites this paper
• Current Advances in Covalent Stabilization of Macromolecular Complexes for Structural Biology.

  2021cites this paper
• Mimics of Diphosphate in ThDP to Improve Pharmacokinetics of Potential Drug Molecules

  2021cites this paper
• The hepatitis B virus polymerase.

  2021cites this paper
• Avoiding Drug Resistance in HIV Reverse Transcriptase.

  2021cites this paper
• Drug Resistance in Liver Diseases

  2021cites this paper
• Understanding the genetics of viral drug resistance by integrating clinical data and mining of the scientific literature

  2021cites this paper
• Zipper head mechanism of telomere synthesis by human telomerase

  2021cites this paper
• Endogenous retroviruses promote homeostatic and inflammatory responses to the microbiota

  2021cites this paper
• Mechanisms of inhibition of viral RNA replication by nucleotide analogs

  2021cites this paper
• A novel mechanism of enhanced transcription activity and fidelity for influenza A viral RNA-dependent RNA polymerase

  2021cites this paper
• HCV RdRp, sofosbuvir and beyond.

  2021cites this paper
• Sliding of HIV-1 reverse transcriptase over DNA creates a transient P pocket – targeting P-pocket by fragment screening

  2021cites this paper
• Structural basis of viral RNA-dependent RNA polymerase nucleotide addition cycle in picornaviruses.

  2021cites this paper
• The Role of Conserved Residues in the DEDDh Motif: the Proton-Transfer Mechanism of HIV-1 RNase H

  2021cites this paper
• Following replicative DNA synthesis by time-resolved X-ray crystallography

  2021cites this paper
• In silico Investigation of Tridax procumbens Phyto-Constituents Against SARS-CoV-2 Infection

  2021cites this paper
• High-resolution view of HIV-1 reverse transcriptase initiation complexes and inhibition by NNRTI drugs

  2021cites this paper
• Oxidative intermediates captured during demethylation of DNA and RNA

  2021cites this paper
• Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V Mutations

  2021cites this paper
• Variability in the Responses of Hepatitis B Virus D-Subgenotypes to Antiviral Therapy: Designing Pan-D-Subgenotypic Reverse Transcriptase Inhibitors

  2021cites this paper
• Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy

  2021cites this paper
• Retroviral reverse transcriptase: Structure, function and inhibition.

  2021cites this paper
• 1,3‐Diketone‐Modified Nucleotides and DNA for Cross‐Linking with Arginine‐Containing Peptides and Proteins

  2021cites this paper
• Adhesion behavior of silica nanoparticles with bacteria: Spectroscopy measurements based on kinetics, and molecular docking

  2021cites this paper
• An Overview of Human Immunodeficiency Virus-1 Antiretroviral Drugs: General Principles and Current Status

  2021cites this paper
• Acceleration of DNA Replication of Klenow Fragment by Small Resisting Force

  2021cites this paper
• Integrative structural biology studies of HIV-1 reverse transcriptase binding to a high-affinity DNA aptamer

  2020cites this paper
• Construction of A Preliminary Three-Dimensional Structure Simian betaretrovirus Serotype-2 (SRV-2) Reverse Transcriptase Isolated from Indonesian Cynomolgus Monkey

  2020influential citation
• Proteins and Disease | Structural Basis of HIV Reverse Transcription, Inhibition, and Drug Resistance

  2020cites this paper
• Kinetic and thermodynamic analysis defines roles for two metal ions in DNA polymerase specificity and catalysis

  2020cites this paper
• Determinants of adenine-mutagenesis in diversity-generating retroelements

  2020influential citation
• Post-Catalytic Complexes with Emtricitabine or Stavudine and HIV-1 Reverse Transcriptase Reveal New Mechanistic Insights for Nucleotide Incorporation and Drug Resistance

  2020cites this paper
• Disulfide bridge cross-linking between protein and the RNA backbone as a tool to study RNase H1.

  2020cites this paper
• Development of Resistance to 4’-Ethynyl-2-Fluoro-2’-Deoxyadenosine (EFdA) by WT and Nucleoside Reverse Transcriptase Inhibitor Resistant Human Immunodeficiency Virus Type 1

  2020cites this paper
• Advances in understanding the initiation of HIV-1 reverse transcription

  2020cites this paper
• The trajectory of intrahelical lesion recognition and extrusion by the human 8-oxoguanine DNA glycosylase

  2020cites this paper
• Magnesium Functions as Superior Co-factor for Measuring Reverse Transcriptase Activity of HIV-1, HIV-2, and SIV

  2020cites this paper
• Distinct Conformational States Underlie Pausing during Initiation of HIV-1 Reverse Transcription.

  2020cites this paper
• Programmed Allelic Mutagenesis of a DNA Polymerase with Single Amino Acid Resolution.

  2020cites this paper
• Novel Coronavirus Polymerase and Nucleotidyl-Transferase Structures: Potential to Target New Outbreaks

  2020cites this paper
• The crosstalk between antiretrovirals pharmacology and HIV drug resistance

  2020cites this paper
• Determinants of Selective Fidelity in Diversity-Generating Retroelements

  2020influential citation
• Fluorescent Tricyclic Cytidine Analogues as Substrates for Retroviral Reverse Transcriptases.

  2020cites this paper
• Small Conformational Changes Underlie Evolution of Resistance to NNRTI in HIV Reverse Transcriptase.

  2020cites this paper
• Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach

  2020cites this paper
• Exploring the Reaction Mechanism of HIV RT with a Nucleotide Substrate.

  2020cites this paper
• Dinuclear Metal-ProPhenol Catalysts: Development and Synthetic Applications.

  2020cites this paper
• Modeling molecular kinetics with Milestoning

  2020cites this paper
• Defective strand-displacement DNA synthesis due to accumulation of thymidine analogue resistance mutations in HIV-2 reverse transcriptase.

  2020cites this paper
• Structural dynamics and susceptibility of anti-HIV drugs against HBV reverse transcriptase

  2020cites this paper
• Role of Divalent Cations in HIV-1 Replication and Pathogenicity

  2020cites this paper
• Stringent control of the RNA-dependent RNA polymerase translocation revealed by multiple intermediate structures

  2020cites this paper
• Replication of DNA containing mirror-image thymidine in E. coli cells.

  2020cites this paper
• Zweikernige Metall‐ProPhenol‐Katalysatoren: Entwicklung und Anwendungen in der Synthese

  2020cites this paper
• Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases.

  2019cites this paper
• Intrinsically Disordered Linkers Impart Processivity on Enzymes by Spatial Confinement of Binding Domains

  2019cites this paper
• HBV Polymerase as a Target for Development of Anti-HBV Drugs

  2019cites this paper
• Design of cross-linked RNA/protein complexes for structural studies.

  2019cites this paper